1 Week Left: Join WFH Global Summit on Advancing Access for Bleeding Disorders Community
The World Federation of Hemophilia (WFH) shared an inviting post on X:
”Just 1 week left until the 2025 WFH Global Policy and Access Summit (GPAS)! Join us for powerful sessions on improving access to diagnosis, treatment, and care for people with bleeding disorders around the world.”
To register for free, follow the link.
WFH is encouraging everyone to not miss the Global Policy and Access Summit (GPAS), happening in just a week.
The upcoming two-day virtual summit will bring together voices from across the bleeding disorders community to focus on one shared goal: expanding access to diagnosis, treatment, and care worldwide.
Presentations and panel discussions will explore strategies to address persistent barriers and highlight successful models from different regions, featuring local and international experts, representatives from national governments, healthcare professionals, WFH National Member Organization (NMO) leaders, and patient advocates working on the front lines.
This summit? It’s more than a meeting—it’s a coordinated step toward equity in care for all people living with bleeding disorders.
To keep up with the news on global conferences and summits, stay informed with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis